The spokesperson did not answer BioPharma Dives questions on PCOS
Research indicates that BPC-157 may inhibit pro-inflammatory cytokines and provide a regenerative environment conducive to the proliferation of progenitor cells [2]
This may help to minimize downtime and discomfort following the fat dissolving treatment, allowing individuals to resume their normal activities more quickly
"At the start of this year, a new 7.2mg dose was approved, with people losing an average of 18.7 per cent of their starting body weight." However, the Wegovy pill is the first of multiple GLP-1 pills which are likely to hit the market over the next few years
The findings, published in Diabetes, Obesity and Metabolism, indicate the potential for TIX100 in weight management programs, although further human clinical trials are necessary to validate these results